Glencoe, IL, United States of America

Charles Polsky

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Beyond Barriers Therapeutics, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Charles Polsky. Retrieved from https://idiyas.com/inventor/charles-polsky

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Charles Polsky and His Patent for CNS Disorder Treatment

Introduction

Charles Polsky is an inventor associated with Glencoe, Illinois. His work includes a patent application focused on sublingual and buccal dosage forms for treating central nervous system disorders.

Latest Patents

Polsky is associated with 1 patent: “Sublingual or Buccal Dosage Forms Comprising Antioxidants for Treatment of Central Nervous System Disorders.” The invention describes dosage forms containing at least one antioxidant, such as N-acetyl cysteine (NAC) or a pharmaceutically acceptable salt. These forms are intended for administration under the tongue or inside the cheek to treat CNS disorders, including traumatic brain injury and stroke.

Career Highlights

Polsky is associated with Beyond Barriers Therapeutics, Inc. His patent-related work reflects an interest in pharmaceutical approaches to neurological conditions.

Collaborations

Polsky’s listed coworker is Ryan Kole. Their association connects them through work related to therapeutic development and the patent described above.

Conclusion

Charles Polsky’s patent focuses on antioxidant-containing sublingual or buccal treatments for CNS disorders, including traumatic brain injury and stroke.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…